Norfolk Island

Reimbursed Care Access

Norfolk Island is subject to Australian Commonwealth health law and the island’s public health programs (Medicare, PBS) were extended to Norfolk Island from 1 July 2016; therefore Australian regulatory decisions (TGA scheduling, PBS listings, state/territory controlled‑drugs rules) govern therapeutic access and reimbursement for psychedelics on the island. In practice, this means: (a) esketamine (Spravato®) is an approved TGA medicine and (b) psilocybin and MDMA may be prescribed only under tightly controlled TGA Authorised Prescriber pathways (not broadly reimbursed), while classic tryptamines, mescaline, ibogaine, ayahuasca and 2C‑series compounds remain prohibited outside research. [https://www.infrastructure.gov.au/territories-regions-cities/territories/norfolk-island/governance-administration|Australian Govt - Norfolk Island governance] [https://www.tga.gov.au/news/update-mdma-and-psilocybin-access-and-safeguards-1-july-2023|TGA: Update on MDMA and psilocybin] [https://www.tga.gov.au/resources/auspmd/spravato|TGA: Spravato]